IMFINZI (Durvalumab) 120 mg Injection
IMFINZI Durvalumab 120 mg Injection is an advanced cancer immunotherapy medicine used in modern oncology treatment. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) blocking antibody that helps the immune system recognize and destroy cancer cells more effectively. It is commonly used in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and biliary tract cancers, often as maintenance or combination therapy after chemotherapy or radiotherapy.
This medicine belongs to immune checkpoint inhibitor therapy and works by strengthening the body’s immune response against cancer progression.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 120 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 proteins on cancer cells
- Reactivating T-cell immune response
- Enhancing immune system ability to fight tumors
- Slowing or stopping cancer progression
Uses and Treatments
IMFINZI (Durvalumab) 120 mg Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer
- Bladder and urothelial cancers (selected cases)
- Maintenance therapy after chemoradiation
Dosage and How to Use
- Administered as intravenous infusion in hospital/clinical settings only
- Given every 2–4 weeks depending on treatment protocol
- Dose is determined by oncologist based on patient condition
- Must be used strictly under medical supervision
Advantages of IMFINZI (Durvalumab)
- Strengthens immune system to fight cancer cells
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiotherapy
- Targeted immunotherapy with precise mechanism
- Helps delay disease progression and recurrence
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vial
- For hospital/oncology use only
Alternative Indian Brands / Options
Durvalumab is a patented immunotherapy, so no direct Indian generic equivalent exists. However, similar immune checkpoint inhibitors include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Oncology biosimilars and cancer therapies from Dr. Reddy’s Laboratories
All alternatives must be prescribed only by an oncologist.
Buy IMFINZI Durvalumab 120 mg Injection Online in South Africa – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 120 mg Injection in South Africa? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure global delivery across South Africa.
We supply advanced immunotherapy medicines used in modern cancer treatment protocols with strict pharmaceutical standards and reliable international logistics.
Coverage includes major cities such as:
Johannesburg, Cape Town, Pretoria, Polokwane, Germiston, and Nelspruit.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure international delivery
- 100% genuine pharmaceutical products
- Reliable global healthcare supply chain
- Expert support for hospital procurement
- Buy Durvalumab 120 mg South Africa
- IMFINZI injection price Johannesburg Cape Town
- Lung cancer immunotherapy South Africa
- PD-L1 inhibitor medicine Africa
- Cancer immunotherapy injection South Africa
- Oncology medicine exporter South Africa
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across South Africa!
